Seeking Alpha
 

EDAP TMS S.A. (EDAP)

- NASDAQ
  • Thu, Aug. 27, 7:43 AM
    • EDAP TMS SA (EDAP +3.9%) Q2 results (€): Revenues: 7.8M (+39.3%); Gross Profit: 3.3M (+83.3%); R&D Expense: 0.7M (-22.2%); SG&A: 2.8M (+12.0%); Operating Loss: (0.2M) (+87.5%); Net Income: 0.5M (+109.4%); EPS: 0.02 (+108.7%); Quick Assets: 11.9M (+5.3%).
    • No guidance given.
    | Thu, Aug. 27, 7:43 AM | Comment!
  • Wed, Aug. 26, 5:35 PM
    • Top gainers, as of 5.25 p.m.: NQ +22.0%. NOK +9.0%. EDAP +8.7%. GPS +5.5%. PSEC +4.0%.
    • Top losers, as of 5.25p.m.: VNET -7.4%. WSM -6.1%. TLYS -5.7%. GES -4.7%. RJET -3.3%.
    | Wed, Aug. 26, 5:35 PM | 13 Comments
  • Wed, Aug. 26, 4:27 PM
    • EDAP TMS S.A. (NASDAQ:EDAP): Q2 EPS of €0.02 vs. -€0.23 in 2Q14
    • Revenue of €7.84M (+39.3% Y/Y)
    • Press Release
    | Wed, Aug. 26, 4:27 PM | 1 Comment
  • Tue, Jul. 21, 9:16 AM
    • EDAP TMS SA (NASDAQ:EDAP) receives a Deficiency List from the FDA in response to its Direct De Novo 510(k) application seeking clearance for Ablatherm HIFU (High Intensity Focused Ultrasound). The deficiencies must be corrected before approval is granted.
    • There are four specific items that the company needs to address: 1. the results of its reprocessing validation tests; 2. additional information regarding its physician training program; 3. additions and modifications to the draft labeling and 4. additions and modifications to the draft user manual.
    • The company intends to submit the information as soon as possible.
    • Ablatherm HIFU is currently cleared for sale in Europe, Canada, Australia and certain other countries.
    • Shares are up 5% premarket but only on turnover of 2,000 shares.
    | Tue, Jul. 21, 9:16 AM | Comment!
  • Tue, Jul. 14, 8:47 AM
    • Lyon, France-based EDAP TMS SA (NASDAQ:EDAP) appoints Francois Dietsch as Chief Financial Officer effective immediately. Previously, he was Group Financial Control Manager and Finance Manager of the firm's French subsidiary.
    | Tue, Jul. 14, 8:47 AM | Comment!
  • Thu, Jul. 2, 8:41 AM
    • EDAP TMS SA (NASDAQ:EDAP) Chief Financial Officer Eric Soyer announces his resignation effective August 31 to accept a senior position at a publicly traded biotech. A successor will be named in the near future.
    | Thu, Jul. 2, 8:41 AM | Comment!
  • Wed, Jun. 3, 5:40 PM
    | Wed, Jun. 3, 5:40 PM | 7 Comments
  • Thu, May 28, 5:40 PM
    | Thu, May 28, 5:40 PM | 2 Comments
  • Wed, May 13, 8:45 AM
    • EDAP TMS SA (EDAP +1.4%) Q1 results: Revenues: $6.9M (-34.9%); COGS: $4M (-31.0%); R&D Expense: $0.86M (-8.5%); SG&A: $2.7M (-15.6%); Operating Loss: ($0.7M) (-187.5%); Net Loss: ($2.7M) (-325.0%); Loss Per Share: ($0.11) (-320.0%); Quick Assets: $12.1M (-17.7%).
    • No guidance given.
    | Wed, May 13, 8:45 AM | Comment!
  • Tue, May 12, 4:27 PM
    • EDAP TMS S.A. (NASDAQ:EDAP): Q1 EPS of -$0.11 misses by $0.14.
    • Revenue of $6.9M (-35.1% Y/Y) misses by $2.67M.
    • Press Release
    | Tue, May 12, 4:27 PM | Comment!
  • Thu, Apr. 2, 6:40 AM
    • EDAP TMS SA (EDAP -0.8%) Q4 results: Revenues: $8M (-27.3%); COGS: $5M (-24.2%); R&D Expense: $0.7M (-12.5%); SG&A: $3.6M (+5.9%); Operating Loss: ($1.3M) (-533.3%); Net Loss: ($3.3M) (-312.5%); Loss Per Share: ($0.13) (-225.0%).
    • FY2014 results: Revenues: $35.4M (+10.6%); COGS: $20.6M (+5.1%); R&D Expense: $3.9M (+11.4%); SG&A: $13.2M (+4.8%); Operating Loss: ($2.3M) (+37.8%); Net Loss: ($0.7M) (+89.6%); Loss Per Share: ($0.03) (+90.6%); Quick Assets: $14.5M (+3.6%).
    • No guidance given.
    | Thu, Apr. 2, 6:40 AM | Comment!
  • Wed, Apr. 1, 5:39 PM
    | Wed, Apr. 1, 5:39 PM | 5 Comments
  • Wed, Apr. 1, 4:25 PM
    • EDAP TMS S.A. (NASDAQ:EDAP): Q4 EPS of -$0.13
    • Revenue of $8M (-27.6% Y/Y)
    • Press Release
    | Wed, Apr. 1, 4:25 PM | Comment!
  • Mon, Mar. 9, 5:40 PM
    | Mon, Mar. 9, 5:40 PM | 1 Comment
  • Fri, Jan. 9, 12:47 PM
    | Fri, Jan. 9, 12:47 PM | 2 Comments
  • Fri, Jan. 9, 10:10 AM
    • Thinly-traded nano cap (EDAP +41.4%) jumps on a 10x surge in volume in response to Health Canada's clearance of the company's Focal One HIFU device for the treatment of prostate cancer.
    | Fri, Jan. 9, 10:10 AM | Comment!
Visit Seeking Alpha's
EDAP vs. ETF Alternatives
Company Description
Edap TMS SA is a holding company. The Company through its divisionsHIFU and UDS,develops, produces and markets minimally invasive medical devices for urological diseases. Its divisionsoperate in Europe, the Americas, Asia and the rest of the world.